Volume 10, Number 2—February 2004
THEME ISSUE
2004 SARS Edition
Preparedness and Response
Crisis Prevention and Management during SARS Outbreak, Singapore
Stella R. Quah*
and Lee Hin-Peng*
and Lee Hin-Peng*
Table 3
Practice of SARS preventive measures, 3 days before interviewsa
| Variable | No. | OR | 95% CI | |
|---|---|---|---|---|
| Personal health evaluation
Symptoms in past 2 weeks
None
One or more
Anxietyb
Moderate or high (score ≤3.25)
Low anxiety (score >3.25)
Perceived likelihood of SARS
Not likely
Likely |
932
269
544
657
1,034
167 |
1.012
0.960
0.861
1.140
1.031
0.833 |
0.947 to 1.082
0.766 to 1.203
0.757 to 0.978
1.031 to 1.283
0.979 to 1.085
0.621 to 1.118 |
|
| Knowledge of SARS
Two or fewer correct answers
Three correct answers |
952
249 |
1.012
0.954 |
0.950 to 1.079
0.753 to 1.079 |
|
| Appraisal of crisis management
Quality of official information
Below average (negative)
Above average (positive)
Have chance to express opinionc
Disagree
Agree
Agreeable to quarantine when non-close contact with SARS-infected person and no symptoms
Agree
Do not agree or don’t know |
290
911
271
930
860
341 |
1.164
0.955
1.434
0.909
0.969
1.084 |
0.928 to 1.460
0.893 to 1.020
1.115 to 1.846
0.855 to 0.966
0.899 to 1.045
0.888 to 1.323 |
|
| Demographic characteristics Years of formal educationd ≤10 >10 Sexc Male Female Agec (y) <35 ≥35 | 686 515 599 602 391 809 | 0.909 1.143 1.339 0.770 1.365 .872 | 0.821 to 1.006 0.985 to 1.325 1.166 to 1.539 0.689 to 0.861 1.123 to 1.658 0.806 to 0.943 | |
aSARS, severe acute respiratory syndrome; OR, odds ratio; CI, 95% confidence interval.
bAsymptotic significance (2-sided) ≤0.05.
cAsymptotic significance (2-sided) ≤0.001.
dAsymptotic significance (2-sided) ≤0.10.
Page created: January 24, 2011
Page updated: January 24, 2011
Page reviewed: January 24, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.